Erratum to: Purinergic Signalling

DOI 10.1007/s11302-007-9078-7

In Table 1, at line 8 after P2Y14: “IP3” should be changed to “↓cAMP”.

Table 1 Receptor classification, intracellular signalling, ligands and selective agonists and antagonists
Full size table

In Fig. 2, lower left in the VSMC: P2Y12 should be P2Y2.

Fig. 2
figure 1

Functional roles of P2 receptors in the atherosclerotic inflammatory plaque and during restenosis. See text for details. Purines and pyrimidines acting on P2 receptors stimulate vascular inflammation both by actions on the endothelial cell (EC) and by effects on inflammatory cells. Furthermore, they stimulate vascular smooth muscle cell (VSCM) proliferation, the conversion to synthetic phenotype and production of matrix proteins. Mitogenic P2 receptors are upregulated by growth factors and cytokines. IL interleukin, MCP-1 monocyte chemoattractant protein-1, ICAM-1 intercellular adhesion molecule-1, TSP thrombospondin, IDO indoleamine 2,3-dioxygenase

Full size image